Inhibitors of dopamine inactivating systems as antiparkinson drugs.
Youdim
M B
MB
Technion-Faculty of Medicine, Rappaport Family Research Institute, Department of Pharmacology, Haifa, Israel.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D065098:Catechol O-Methyltransferase Inhibitors; D018492:Dopamine Antagonists; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D018492:Dopamine Antagonists; D008996:Monoamine Oxidase Inhibitors; D011954:Receptors, Dopamine; D007980:Levodopa